Advanced Search

The American Journal of Psychiatry, VOL. 97, No. 3

Article | November 01, 1940

THE TREATMENT OF THE PARKINSONIAN SYNDROME WITH BULGARIAN BELLADONNA ROOT AND AMPHETAMINE (BENZEDRINE) SULFATE

EUGENE DAVIDOFF; EDWARD C. REIFENSTEIN; NOBLE R. CHAMBERS

Am J Psychiatry 1940;97:589-600.

View Article Information

The department of psychiatry, College of Medicine, Syracuse University; and from the Syracuse Psychopathic Hospital.

Article

text A A A

PDF of the full text article.

Abstract

1. A series of 25 patients with Parkinsonian syndrome, including 15 of the post-encephalitic type, and 10 of the arteriosclerotic or idiopathic type have been treated with the combination of Bulgarian belladonna root (rabellon) and amphetamine (benzedrine) sulfate. Of the post-encephalitic cases, 11 showed some improvemnet. Of the other types, five were beneficially influenced.2. Our experience indicated that this therapy is superior to other forms of treatment.

Figures in this Article

Your Session has timed out. Please sign back in to continue.

Username

Password

Sign in via Athens (What is this?)

Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.

Forgot Password?

Not a subscriber?

Subscribe Now/Learn More

Purchase Online access to this article for 24 hours

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.

Submit a Comments

Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

* = Required Field

Comment Author(s)*(if multiple authors, separate names by comma)

Example: John Doe

Affiliation & Institution*

Comment Title*

Comment*

Cancel

Topics

Product Recommendation

CME Activity